DCF Advisers’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,300
Closed -$249K 84
2023
Q4
$249K Sell
1,300
-500
-28% -$85.2K 0.17% 69
2023
Q3
$319K Buy
1,800
+200
+13% +$38.2K 0.22% 69
2023
Q2
$304K Buy
1,600
+200
+14% +$39.7K 0.21% 75
2023
Q1
$280K Hold
1,400
0.21% 57
2022
Q4
$333K Hold
1,400
0.26% 54
2022
Q3
$280K Sell
1,400
-3,600
-72% -$687K 0.21% 65
2022
Q2
$729K Sell
5,000
-14,000
-74% -$1.99M 0.49% 44
2022
Q1
$3.1M Buy
19,000
+1,000
+6% +$152K 1.82% 21
2021
Q4
$3.05M Buy
18,000
+500
+3% +$92.9K 1.54% 23
2021
Q3
$3.3M Hold
17,500
1.8% 22
2021
Q2
$2.97M Sell
17,500
-2,500
-13% -$366K 1.49% 25
2021
Q1
$2.82M Hold
20,000
1.43% 24
2020
Q4
$2.6M Sell
20,000
-7,500
-27% -$1M 1.39% 27
2020
Q3
$4M Hold
27,500
2.5% 17
2020
Q2
$4.07M Sell
27,500
-1,500
-5% -$202K 2.78% 13
2020
Q1
$3.16M Sell
29,000
-11,000
-28% -$1.27M 2.73% 16
2019
Q4
$4.61M Buy
+40,000
New +$3.99M 3.55% 11

Other funds holding ALNY